| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/06/2001 | WO2001091540A1 Apparatus for diagnosis of growing state of plant under raising in nutriculture |
| 12/06/2001 | WO2001071345A8 Optically and fluidically enhanced in vitro diagnostic test chamber |
| 12/06/2001 | WO2001068805A8 Human olfactory receptors and genes encoding same |
| 12/06/2001 | WO2001055704A8 System for transferring fluid samples through a sensor array |
| 12/06/2001 | WO2001052614A3 Selecting and producing t cell peptide epitopes |
| 12/06/2001 | WO2001049790A3 Mobility-modifying cyanine dyes |
| 12/06/2001 | WO2001049717A3 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity |
| 12/06/2001 | WO2001046686A3 Chromatography material and a method using same |
| 12/06/2001 | WO2001046224A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/06/2001 | WO2001044819A3 Hematological assay and reagent |
| 12/06/2001 | WO2001042793A3 Diagnostic assay for stroke |
| 12/06/2001 | WO2001042790A3 Agents and method for diagnosing lyme disease and borreliosis vaccine |
| 12/06/2001 | WO2001040804A3 Clearance of aberrant protein in correlation with disease |
| 12/06/2001 | WO2001040509A3 Dynamic determination of analytes |
| 12/06/2001 | WO2001038877A9 Multiblot kinase analysis |
| 12/06/2001 | WO2001038869A3 System for determination of wastewater biodegradability |
| 12/06/2001 | WO2001036670A3 Diagnosis kit, method and microarray for determining human detoxification capacity |
| 12/06/2001 | WO2001034834A3 Endogenous gene expression assay |
| 12/06/2001 | WO2001034201A3 Methods for inhibiting neurofibromatosis type 1 (nf1) |
| 12/06/2001 | WO2001030854A3 Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin |
| 12/06/2001 | WO2001027630A3 Methods to identify compounds that modulate neuronal activity |
| 12/06/2001 | WO2001023607A3 Multiplex pcr for detecting ehec infections |
| 12/06/2001 | WO2001022922A3 Engineering antibodies that bind irreversibly |
| 12/06/2001 | WO2001018246A8 Microfluidic and nanofluidic electronic devices for detecting changes in capacitance of fluids and methods of using |
| 12/06/2001 | WO2001018042A3 Apoptosis proteins |
| 12/06/2001 | WO2001012775A8 25 human secreted proteins |
| 12/06/2001 | WO2001012662A3 Membrane associated proteins |
| 12/06/2001 | WO2001011359A3 Color space analysis in biochemical and immunological assays |
| 12/06/2001 | WO2001011075A3 Pcr-based detection and quantification of tapesia yallundae and tapesia acuformis |
| 12/06/2001 | WO2001007912A3 Immunoassay for pesticides and their degradation products |
| 12/06/2001 | WO2000077206A3 The myostatin gene promoter and inhibition of activation thereof |
| 12/06/2001 | WO2000063427A3 Compound screening method |
| 12/06/2001 | WO2000061750A3 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS |
| 12/06/2001 | WO2000011166A9 14274 receptor, a g-protein coupled receptor related to the edg receptor family |
| 12/06/2001 | WO2000011036A9 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120 |
| 12/06/2001 | WO2000006599A8 Inhibitors of hiv membrane fusion |
| 12/06/2001 | US20010049586 Iterative analysis of non-responding population in the design of pharmacogenetic studies |
| 12/06/2001 | US20010049477 Method and apparatus for in vivo measurement of carbon monoxide production rate |
| 12/06/2001 | US20010049470 Diet and activity monitoring device |
| 12/06/2001 | US20010049437 Electrophoretic separation of nucleic acids from proteins at low ph |
| 12/06/2001 | US20010049435 Myostatin gene promoter and inhibition of activation thereof |
| 12/06/2001 | US20010049360 Betaglycan as an inhibin receptor and uses thereof |
| 12/06/2001 | US20010049348 Interaction of NMDA receptor with protein tyrosine phosphatase |
| 12/06/2001 | US20010049184 A second metal electrode forms a Schottky contact with said semiconductor film; the thickness and material of said second metal electrode enables a Schottky barrier height to decrease when hydrogen gas is contacted |
| 12/06/2001 | US20010049146 Stabilization of biological fluids by addition of sterol esters |
| 12/06/2001 | US20010049137 DNA fragments derived from the genomic DNA of HPV-33, including recombinant vectors, which cells are replicated in host cells and expressed as immunogenic proteins; diagnosis of tumors; antibodies to detect viral infections |
| 12/06/2001 | US20010049121 Polypeptides and polynucleotides; drug screening, use in therapy, diagnostic assays |
| 12/06/2001 | US20010049117 Uridine diphosphate N-acetylmuramyl peptide (UDP-MURNAC) analog with capture moiety; substrate for enzyme in bacterial cell wall biosynthesis; screening for new antibiotics |
| 12/06/2001 | US20010049116 Incubating the sample with a solubilization buffer to solubilize a molecular marker of the parasite and detecting at a given concentration; kits for immunoassay; water testing, fecal testing |
| 12/06/2001 | US20010049115 Vitro model for gastrointestinal inflammation |
| 12/06/2001 | US20010049114 Using a computer-aided image analysis system to enhance and process optical images of an immunohistochemically stained tissue or cell sample, and to determine the optical density of the stained tissue or cell sample; cancer diagnosis |
| 12/06/2001 | US20010049113 Treating a vial infection which uses the host cell Ras pathway with agents that inhibit Ras pathway, agents that promote protein kinase (PKR) phosphorylation, or that promote translation initiation factor eIF-2 alpha phosphorylation |
| 12/06/2001 | US20010049112 Detection and determination of the stages of coronary artery disease |
| 12/06/2001 | US20010049111 Methods, procedures, and formats for using microelectronic array devices to perform multiplex immunoassay analyses |
| 12/06/2001 | US20010049109 Comprising a donor dye having a specified absorption maxima, and an acceptor dye capable of absorbing excitation energy emitted by the donor dye and emitting light in response of given emission maxima |
| 12/06/2001 | US20010049108 Methods for reducing non-specific binding to an oligonucleotide array |
| 12/06/2001 | US20010049106 ADAM (A Disintegrin And Metalloprotease) family of metalloproteases, and in addition contain thrombospondin domain (TS); treating diabetes, arthritis, cancer, solid tumors, autoimmune diseases |
| 12/06/2001 | US20010049099 Synthesis of macromolecules on a tape-like substrate material with no dead time |
| 12/06/2001 | US20010049093 Inhibition of viral gene activities |
| 12/06/2001 | US20010049092 Method and device for drug-drug interaction testing sample preparation |
| 12/06/2001 | US20010049091 Use of fluorescent reagents in identification of cancerous cells and activated lymphocytes |
| 12/06/2001 | US20010049090 Immobilized on solid support; encoded with label |
| 12/06/2001 | US20010048961 Method and system for controlling mixing processes |
| 12/06/2001 | US20010048929 Novel multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| 12/06/2001 | US20010048928 Herpesvirus particles comprising fusion protein and their preparation and use |
| 12/06/2001 | US20010048927 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia |
| 12/06/2001 | US20010048923 Immune cell regulation with src ptk sequestering agents |
| 12/06/2001 | US20010048917 Skin equivalent and methods of forming and using same |
| 12/06/2001 | US20010048915 Decreased endogenous nitric oxide activation |
| 12/06/2001 | US20010048900 Jet vortex mixer |
| 12/06/2001 | US20010048895 Laboratory in a disk |
| 12/06/2001 | US20010047966 Filtering sample of digested natural sources such as cells or cell fragments using filter the pore size of which decreases in direction of flow of sample through filter |
| 12/06/2001 | US20010047679 Device and method for determining friction |
| 12/06/2001 | DE19963660A1 Determining specific T cells, present at low frequency, useful, e.g. for diagnosis and development of tumor vaccine, based on reaction with HLA Class I tetramers |
| 12/06/2001 | DE10026942A1 Verfahren zur Steuerung einer Texturiermaschine sowie eine Texturiermaschine Method for controlling a texturing machine and a texturing |
| 12/06/2001 | DE10025820A1 New asymmetric polymethin dyes with substituted benz(b)pyran-4-ylidene-alk-1-enyl and nitrogen-heterocyclic units, used as optical markers for protein, nucleic acid, oligomer, cell, lipid, polymer or pharmaceuticals |
| 12/06/2001 | DE10025620A1 New nucleic acid encoding chimeric potassium channel protein, useful, when immobilized on carrier, in screening agents for toxicity and pharmaceutical activity |
| 12/06/2001 | DE10025174A1 Verfahren zur Herstellung einer mit Biomolekülen beschichteten Elektrode A process for producing a surface coated with biomolecules electrode |
| 12/06/2001 | CA2843053A1 Systems and methods for monitoring health and delivering drugs transdermally |
| 12/06/2001 | CA2688795A1 Systems and methods for monitoring health and delivering drugs transdermally |
| 12/06/2001 | CA2532148A1 Methods to identify compounds that modulate rage |
| 12/06/2001 | CA2421031A1 No wash bead assay, kit and procedure |
| 12/06/2001 | CA2415224A1 Methods for using mass spectrometry to identify and classify filamentous fungi, yeasts, molds and pollen |
| 12/06/2001 | CA2414017A1 Inhibiting retrotransposon and retroviral integration by targeting the atm pathway |
| 12/06/2001 | CA2413855A1 Surface for the immobilisation of ligands |
| 12/06/2001 | CA2412321A1 Detection system for sorting apparatus |
| 12/06/2001 | CA2411655A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | CA2411404A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 12/06/2001 | CA2411304A1 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/06/2001 | CA2410950A1 Methods for detecting target nucleic acids using coupled ligation and amplification |
| 12/06/2001 | CA2410949A1 Novel target genes for diseases of the heart |
| 12/06/2001 | CA2410944A1 Cartilage replacement and method for its production |
| 12/06/2001 | CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 12/06/2001 | CA2410912A1 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | CA2410907A1 Dual beam ftir methods and devices for analyte detection in samples of low transmissivity |
| 12/06/2001 | CA2410823A1 Assay for kinases and phosphatases |
| 12/06/2001 | CA2410736A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof |
| 12/06/2001 | CA2410734A1 Dnas encoding mammalian histamine receptor of the h4 subtype |
| 12/06/2001 | CA2410726A1 Structure-based methods for assessing amino acid variances |
| 12/06/2001 | CA2410684A1 Method to determine the differentiation potential of a target cell |